Similar articles for PMID: 3373302

Year	Number of Results
1983	1
1984	5
1985	3
1986	3
1987	4
1988	3
1989	6
1990	12
1991	7
1992	3
1994	3
1995	1
1999	3
2000	1
2002	1
2003	1
2004	1
2023	0

1

Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy.

Granowska M, Nimmon CC, Britton KE, Crowther M, Mather SJ, Slevin ML, Shepherd JH. Granowska M, et al. J Nucl Med. 1988 May;29(5):599-607. J Nucl Med. 1988. PMID: 3373302 Free article.

2

Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours.

Granowska M, Mather SJ, Jobling T, Naeem M, Burchell J, Taylor-Papadimitriou J, Shepherd J, Britton KE. Granowska M, et al. Int J Biol Markers. 1990 Apr-Jun;5(2):89-96. doi: 10.1177/172460089000500208. Int J Biol Markers. 1990. PMID: 2283483

3

Radioimmunoscintigraphy with Tc-99m-labelled SM3 in differentiating malignant from benign adnexal masses.

Ali N, Jan H, Van Trappen P, Nasreen F, Canizales A, Carroll MJ, Granowska M, Jacobs I, Britton KE. Ali N, et al. BJOG. 2003 May;110(5):508-14. BJOG. 2003. PMID: 12742337

4

A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer.

Granowska M, Britton KE, Shepherd JH, Nimmon CC, Mather S, Ward B, Osborne RJ, Slevin ML. Granowska M, et al. J Clin Oncol. 1986 May;4(5):730-6. doi: 10.1200/JCO.1986.4.5.730. J Clin Oncol. 1986. PMID: 3701391

5

Radioimmunoscintigraphy of ovarian cancer.

Granowska M, Britton KE. Granowska M, et al. Dis Markers. 1991 May-Aug;9(3-4):191-5. Dis Markers. 1991. PMID: 1725973 No abstract available.

6

Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.

Pateisky N, Philipp K, Sevelda P, Skodler WD, Enzelsberger H, Hamilton G, Burchell J, Schatten C. Pateisky N, et al. Gynecol Obstet Invest. 1987;24(3):211-6. Gynecol Obstet Invest. 1987. PMID: 3692333

7

Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".

Barzen G, Hierholzer J, Cordes M, Friedmann W, Felix R. Barzen G, et al. Int J Rad Appl Instrum B. 1991;18(1):69-76. doi: 10.1016/0883-2897(91)90050-u. Int J Rad Appl Instrum B. 1991. PMID: 2010310 No abstract available.

8

[Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma].

Barzen G, Cordes M, Langer M, Friedman W, Mayr AC, Felix R. Barzen G, et al. Rofo. 1990 Jul;153(1):85-91. doi: 10.1055/s-2008-1033338. Rofo. 1990. PMID: 2166319 German.

9

Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.

Barzen G, Mayr AC, Langer M, Becker R, Cordes M, Zwicker C, Koppenhagen K, Felix R. Barzen G, et al. Eur J Nucl Med. 1989;15(1):42-8. doi: 10.1007/BF00253598. Eur J Nucl Med. 1989. PMID: 2917583

10

[Visualization of malignant tumors in the abdomen using radiolabelled monoclonal antibodies].

Pateisky N, Philipp K, Burchell J, Skodler W. Pateisky N, et al. Geburtshilfe Frauenheilkd. 1984 Oct;44(10):623-6. doi: 10.1055/s-2008-1036319. Geburtshilfe Frauenheilkd. 1984. PMID: 6097499 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed